A critical advance in cancer investigation is arising with the use of nanobodies to restore dysfunctional p53. This vital tumor inhibitor protein is frequently lost in various forms of malignancies, leading https://socialskates.com/story23425926/mini-antibodies-reactivate-p53-new-new-pathway-for-cancer-management